Patents by Inventor Matthew Allister Lambert

Matthew Allister Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-GDF15 antibodies, compositions and methods of use
    Patent number: 11566066
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: January 31, 2023
    Assignee: Pfizer Inc.
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar
  • ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE
    Publication number: 20220380448
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Application
    Filed: August 1, 2022
    Publication date: December 1, 2022
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar
  • ANTI-IL-33 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
    Publication number: 20200308272
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
    Type: Application
    Filed: December 29, 2019
    Publication date: October 1, 2020
    Inventors: Laird BLOOM, Karl Henry NOCKA, James Reasoner APGAR, Matthew Allister LAMBERT, Mark A. FARMER
  • ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE
    Publication number: 20200055930
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 20, 2020
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar
  • Anti-IL-33 antibodies, compositions, methods and uses thereof
    Patent number: 10544212
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: January 28, 2020
    Assignee: Pfizer Inc.
    Inventors: Laird Bloom, Karl Henry Nocka, James Reasoner Apgar, Matthew Allister Lambert, Mark A. Farmer
  • ANTI-IL-33 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
    Publication number: 20180037644
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
    Type: Application
    Filed: April 24, 2017
    Publication date: February 8, 2018
    Inventors: Laird BLOOM, Karl Henry NOCKA, James Reasoner APGAR, Matthew Allister LAMBERT, Mark A. FARMER
  • HUMANIZED ANTI-RAGE ANTIBODY
    Publication number: 20100143349
    Abstract: Compositions comprising antigen binding polypeptides that bind specifically to Receptor For Advanced Glycation End-product (RAGE) and comprises: one or more complementarity determining regions (CDRs) with improved binding efficiency over a parental monoclonal antibody to RAGE are described. Antibodies containing the CDR's and methods of treating a RAGE-related disease or disorder comprising administering to the subject a therapeutically effective amount of the compositions of the invention are also provided.
    Type: Application
    Filed: August 12, 2009
    Publication date: June 10, 2010
    Applicant: Wyeth
    Inventors: Simon Evan Hufton, William James Jonathan Finlay, Orla Margaret Cunningham, Alfredo Darmanin Sheehan, Xuemei Germaine, Matthew Allister Lambert